DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$23.50 at National Bank Financial

DRI Healthcare Trust (TSE:DHT.UN) had its price objective raised by analysts at National Bank Financial from C$22.50 to C$23.50 in a research note issued on Tuesday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. National Bank Financial’s price target would suggest a potential upside of 44.70% from the stock’s current price.

Other analysts have also recently issued reports about the stock. Stifel Nicolaus boosted their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company a “buy” rating in a research note on Thursday, April 2nd. Scotiabank boosted their price objective on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the company a “sector outperform” rating in a research note on Tuesday. Five investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of C$22.30.

DRI Healthcare Trust Stock Up 0.6%

Shares of TSE DHT.UN traded up C$0.10 during trading on Tuesday, hitting C$16.24. 118,020 shares of the company traded hands, compared to its average volume of 42,893. DRI Healthcare Trust has a 1 year low of C$12.51 and a 1 year high of C$17.69. The company has a 50-day moving average price of C$16.59 and a 200-day moving average price of C$16.28. The firm has a market capitalization of C$893.48 million, a P/E ratio of -18.04 and a beta of 0.35.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.